Table 4.
Association between DoNA practices and characteristics of participants.
| Measures | Score | p-Values | |
|---|---|---|---|
| Mean ± SD | Age | Education | |
| Before DoNA, I inquire thedrug allergies to patients | 3.7 ± 0.10 | 0.050 | 0.572 |
| Before DoNA, I inquire about the renal condition of patients | 2.5 ± 0.06 | 0.048 | 0.162 |
| Before DoNA, I ask the patient about other disease/s or therapies | 4.9 ± 0.13 | 0.573 | 0.201 |
| At the time of DoNA, I inform the patients about possible side effects | 3.0 ± 0.08 | 0.047 | 0.411 |
| At the time of DoNA, I counsel the patients for medication adherence and compliance | 5.2 ± 0.14 | 0.172 | 0.070 |
| I don’t dispense non-prescribed antibiotics for children | 2.7 ± 0.07 | 0.701 | 0.090 |
| I don’t dispense non-prescribed antibiotics for pregnant women | 3.0 ± 0.08 | 0.849 | 0.385 |
p-values < 0.05 = statistically significant; Mean value and score weighting from 6-point Likert scale (1 = never, 2 = very rarely, 3 = rarely, 4 = some time, 5 = very often, 6 = always).